1. Home
  2. CPHI vs NBY Comparison

CPHI vs NBY Comparison

Compare CPHI & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPHI
  • NBY
  • Stock Information
  • Founded
  • CPHI N/A
  • NBY 2000
  • Country
  • CPHI China
  • NBY United States
  • Employees
  • CPHI N/A
  • NBY N/A
  • Industry
  • CPHI Biotechnology: Pharmaceutical Preparations
  • NBY
  • Sector
  • CPHI Health Care
  • NBY
  • Exchange
  • CPHI Nasdaq
  • NBY Nasdaq
  • Market Cap
  • CPHI 5.3M
  • NBY 6.3M
  • IPO Year
  • CPHI N/A
  • NBY 2007
  • Fundamental
  • Price
  • CPHI $1.51
  • NBY $1.06
  • Analyst Decision
  • CPHI
  • NBY
  • Analyst Count
  • CPHI 0
  • NBY 0
  • Target Price
  • CPHI N/A
  • NBY N/A
  • AVG Volume (30 Days)
  • CPHI 8.2K
  • NBY 203.8K
  • Earning Date
  • CPHI 11-13-2025
  • NBY 11-07-2025
  • Dividend Yield
  • CPHI N/A
  • NBY N/A
  • EPS Growth
  • CPHI N/A
  • NBY N/A
  • EPS
  • CPHI N/A
  • NBY 0.47
  • Revenue
  • CPHI $4,052,266.00
  • NBY $10,302,000.00
  • Revenue This Year
  • CPHI N/A
  • NBY $23.91
  • Revenue Next Year
  • CPHI N/A
  • NBY $32.05
  • P/E Ratio
  • CPHI N/A
  • NBY $40.02
  • Revenue Growth
  • CPHI N/A
  • NBY 73.07
  • 52 Week Low
  • CPHI $1.20
  • NBY $0.46
  • 52 Week High
  • CPHI $3.35
  • NBY $4.44
  • Technical
  • Relative Strength Index (RSI)
  • CPHI 32.84
  • NBY 41.62
  • Support Level
  • CPHI $1.46
  • NBY $1.00
  • Resistance Level
  • CPHI $1.58
  • NBY $1.11
  • Average True Range (ATR)
  • CPHI 0.07
  • NBY 0.07
  • MACD
  • CPHI -0.01
  • NBY 0.01
  • Stochastic Oscillator
  • CPHI 11.57
  • NBY 15.14

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: